NANOVIRICIDES, INC. — Form 8-K
Filed July 17, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 52/100
What the filing says
On July 17, 2026, NanoViricides, Inc. (NNVC) entered into an At Market Issuance Sales Agreement with D. Boral Capital LLC, authorizing the sale of up to $4,018,069 in common stock (par value $0.00001/share) via Form S-3 (File No. 333-296550, effective June 15, 2026). D. Boral Capital acts as sales agent, receiving 2.0% commission on gross proceeds. The company's public market value is approximately $21.5M; this offering represents ~18.7% of that market cap. Settlement occurs T+1; the company retains broad discretion over timing and pricing via Placement Notices.
Why this rating
Material capital raise (~19% of market cap) for a $21.5M company, but typical ATM structure with standard terms. No completion yet; proceeds depend on execution.
Extracted items
See more from July 17, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.